Prioritizing Patients.

Improving Outcomes.

Scienture is focused on bridging gaps in patient treatment delivery systems to improve healthcare outcomes.

We work for a healthier world where the burden of disease is lightened through accessible, affordable, tailored therapies.

Who We Are
Grandmother hugging child.
Lab tech looking through a microscrope.

We discover and deliver selectively designed drug innovations that enhance the treatment experience. It all starts with the patient.

Our Science

Moving beyond traditional therapies, we aim to improve adherence journeys for patients whose needs have been overlooked.

Our Pipeline

Latest News

Press Releases

Scienture Holdings, Inc. Announces Dr. Narasimhan Mani’s Participation in the 8th Annual Conference of The Society for the Study of Xenobiotics

Learn More

Press Releases

Scienture, LLC, a wholly owned subsidiary of Scienture Holdings, Inc. (NASDAQ: SCNX) Announces Issuance of a New Patent Covering its first product SCN-102 (Losartan Potassium Oral Suspension, 10mg/mL) through 2041

Learn More

Updates

Scienture Holdings, Inc. Announces Private Placement of $3 Million of 10% Secured Convertible Debentures as Initial Tranche of $12 Million Offering and Entry into $50 Million Equity Line of Credit Agreement

Learn More

Press Releases

TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. and Ticker Symbol Change to “SCNX”

Learn More

Press Releases

TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc.

Learn More

Press Releases

TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million

Learn More

See all
Lab tech filling vials.

We invest in Delivering Better™

We are focused on identification and thoughtful selection of key access, commercialization, and support partners.

Investor Relations